Información del artículo
El Texto completo está disponible en PDF
Bibliogrífia
[1.]
M.D. Yow, G.J. Demmler.
Congenital cytomegalovirus disease – 20 years is long enough.
N Engl J Med, 326 (1992), pp. 702-703
[3.]
R. Jiménez.
El pretérmino de menos de 1.500 gramos. Introducción.
RELAN, (1998), pp. 49-50
[4.]
S.A. Plotking.
Vaccination against cytomegalovirus, the changeling demon.
Pediatr Infect Dis J, 18 (1999), pp. 313-326
[5.]
A. Pérez Payá, E. Apolinar, B. Acosta, C. Ribes, C. Díaz, A. Muñoz.
Infección perinatal por citomegalovirus en recién nacidos pretérmino.
An Esp Pediatr, 57 (2002), pp. 246-250
[6.]
C.R. De Cates, Gray, N.R. Roberton, J. Walker.
Acquisition of cytomegalovirus infection by premature neonates.
J Infect, 28 (1994), pp. 25-30
[7.]
S.G. Paryani, A.S. Yeager, H. Hosford-Dunn, S.J. Johnson, N. Malachowski, R.L. Ariagno, et al.
Sequela of acquired cytomegalovirus infection in premature and sick terms infants.
Pediatr, 107 (1985), pp. 451-456
[8.]
K. Hamprecht, J. Yaschmannn, Y. Kochen, K. Dietz, C.P. Speer, G. John.
Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding.
Lancet, 357 (2001), pp. 513-518
[9.]
R. Montgomery, L. Youngblood, D.N. Medearis.
Recovery of cytomegalovirus from the cervix in pregnancy.
Pediatrics, 49 (1972), pp. 524-531
[10.]
D.W. Reynolds, S. Stagno, T. Hosty, M. Tiller, C. Alford.
Maternal cytmegalovirus excreción and perinatal infection.
N Engl J Med, 289 (1973), pp. 1-5
[11.]
M. Fewtrell, A. Lucas.
Feeding the full-term infant.
Textbook of Neonatology, 3.a ed, pp. 325-338
[12.]
S. Stagno, D.W. Reynolds, R.F. Pass.
Breast milk and the risk of cytomegalovirus infections.
N Engl J Med, 302 (1980), pp. 1073-1076
[13.]
S. Stagno, G.A. Cloud.
Working parents: The impact of day care and breastfeeding on cytomegalovirus infections in offspring.
Proc Natl Acad Sci (USA), 91 (1994), pp. 2384-2389
[14.]
H. Asanuma, K. Numazaki, N. Nagata, T. Hotsubo, K. Horino, S. Chiba.
Role of milk whey in the transmission of human cytomegalovirus infection by breast milk.
Microbiol Immunol, 46 (1996), pp. 201-204
[15.]
K. Numazaki, S. Chiba, H. Asanuma.
Transmission of cytomegalovirus.
Lancet, 357 (2001), pp. 1799-1800
[16.]
D. Xu, M. Yonetani, Y. Uetani, H. Nakamura.
Acquired cytomegalovirus infection and blood transfusion in preterm infants.
Acta Paediatr, 37 (1995), pp. 444-449
[17.]
E.M. Bifano, T.R. Curran.
Minimización de la exposición a sangre donada en la unidad de cuidados intensivos neonatal.
Clin Perinatol, 3 (1995), pp. 615-627
[18.]
R.G. Strauss.
Practical Issues in Neonatal Transfussion Practice.
Am J Clin Pathol, 107 (1997), pp. 557-563
[19.]
T. Lazzarotto, S. Varani, B. Guerra, A. Nicolosi, M. Lanari, M.P. Landini.
Prenatal indicators of congenital cytomegalovirus infection.
J Pediatr, 137 (2000), pp. 90-95
[20.]
P.D. Griffiths, A. McLean, V.C. Emery.
Encouraging prospects for immunisation against primary cytomegalovirus infection.
Vaccine, 19 (2001), pp. 1356-1362
[21.]
F. Mosca, L. Pugni, M. Barbi, S. Binda.
[carta]. Transmission of cytomegalovirus.
Lancet, 357 (2001), pp. 1800
[22.]
American Academy of Pediatrics.
Workgroup on Breastfeeding. Breast-feeding and the use of human milk.
Pediatrics, 100 (1997), pp. 1035-1039
[23.]
D.R. Snydman, B.G. Werner, H.C. Meissner, C.H. Cheeseman, J. Schwab, F. Bednarek, et al.
Use of cytomegalovirus immuno-globulin in multiply transfused premature neonates.
Pediatr Infect Dis J, 14 (1995), pp. 34-40
[24.]
S. Galea, S.J. Urbaniak.
The incidence and consequences of cytomegalovirus transmission via blood transfusion to low birth weight, premature infants in North East Scotland.
Vox Sang, 62 (1992), pp. 200-207
[25.]
C. Lachance, P. Chessex, J.C. Fouron, J.A. Widness, H. Bard.
Myocardial, erythropoietic and metabolic adaptations to anemia of prematurity.
J Pediatr, 125 (1994), pp. 278-282
[26.]
E.M. Bifano, F. Smith, J. Borer.
Relationship between determinants of oxygen deliver and respiratory abnormalities in preterm infants with anemia.
J Pediatr, 120 (1992), pp. 292-296
[27.]
Fetus and Newborn Committee Canadian Paediatric Society Guidelines for transfusion of erythrocytes to neonates and premature infants.
Can Med Assoc J, 147 (1992), pp. 1781-1786
[28.]
K.M. Schannon, J.F. Keith III, W.C. Mentzer, R.A. Ehrenkranz, M.S. Brown, J.A. Widness, et al.
Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Pediatr, 95 (1995), pp. 1-8
[29.]
J. Ramasethu, L.C. Luban.
Red blood cell transfusions in the newborn.
Semin Neonatal, 4 (1999), pp. 5-16
[30.]
R.G. Strauss, R.A. Sacher, J.F. Blazina.
Commentary on small – volume red cell transfusions for neonatal patients.
Transfusion, 30 (1990), pp. 565-570
[31.]
D.A. Lee, T.A. Slagle, T.M. Jackson, C.S. Evans.
Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packet red blood cells.
J Pediatr, 126 (1995), pp. 280-286
[32.]
R.G. Strauss, P.J. Willhaner, S.G. Corde.
A method to collect, store and issue multiple aliquots of packet red blood cells for neonatal transfusions.
Vox Sang, 68 (1995), pp. 77-81
[33.]
R.G. Strauss, L.F. Burmeister, K. Johnson, T. James, J. Miller, D.G. Cordle, et al.
AS-1 red cells for neonatal transfusions: A randomized trial assessing donor exposure and safety.
Transfusion, 36 (1996), pp. 873-878
[34.]
C.D. Hillyer, R.K. Emmens, M. Zago-Novaretti, E.M. Berkman.
Methods for the reduction of transfusion-transmitted cytomegalovirus infection: Filtration vesus the use of seronegative donor units.
Transfusion, 34 (1994), pp. 929-934
[35.]
L. Eisenfeld, H. Silver, J. McLaughlin.
Prevention of transfusion- associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood.
Transfusion, 32 (1992), pp. 205-209
[36.]
E.A. Letsky.
Use of blood products.
editors. Textbook of Neonatology, 3.a ed, pp. 838-843
[37.]
S.P. Adler.
Molecular epidemiology of cytomegalovirus: A study of factors affecting transmission among children at three day-care centers.
Pediatr Infect Dis J, 10 (1991), pp. 584-590
[38.]
G.J. Demmler.
Infectious Diseases Society of American and Centers for Disease Control: Summary of a Workshop on surveillance for congenital cytomegalovirus disease.
Rev Infect Dis, 13 (1991), pp. 315-329
[39.]
B. Gratacap-Cavallier, J.L. Bosson, P. Morand, N. Dutertre, B. Chanzy, P.S. Jouk, et al.
Cytomegalovirus seroprevalence in French pregnant women: Parity and place of birth as mayor predictive factors.
Eur J Epidemiol, 14 (1998), pp. 147-152
[40.]
C.S. Crumpacker.
Ganciclovir.
N Engl J Med, 335 (1996), pp. 721-729
[41.]
G. Nigro, H. Scholoz, U. Bartmann.
Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: A two regimen experience.
J Pediatr, 124 (1994), pp. 318-322
[42.]
R.J. White, G. Cloud, W. Gruber, G.A. Storch, G.J. Demmler, R.F. Jacobs, et al.
Ganciclovir treatment of syntomatic congenital cytomegalovirus infection: Results of a phase II study.
J Infect Dis, 175 (1997), pp. 1080-1086
[43.]
H. Negiski, H. Yamada, E. Hirayama, K. Okuyama, T. Sagawa, Y. Matsumoto, et al.
Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus.
J Perinatol, 18 (1998), pp. 466-469
[44.]
D.K. Mitchell, S.J. Holmes, R.L. Burke, A.M. Duliege, S.P. Adler.
Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers.
Pediatr Infect Dis J, 21 (2002), pp. 133-138
[45.]
R. Pass, A. Duliege, S. Boppana, R. Sekulovich, Percells, W. Britt, et al.
Subunit cytomegalovirus vaccine based on recombinant envelope glicoprotein B and a new adjuvant.
J Infect Dis, 180 (1999), pp. 970-975
[46.]
G.T. Maine, T. Lazzarotto, M.P. Landini.
New developments in the diagnosis of maternal and congenital CMV infection.
Expert Rev Mol Diagn, 1 (2001), pp. 19-26
Copyright © 2002. Asociación Española de Pediatría
